Xconomy National

Archives

by in

Entry	Author	Date	Location
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug	Luke Timmerman	01/04/12	Boston
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol	Luke Timmerman	03/02/11	Seattle
How Lilly Let Telaprevir Go to Vertex, SV Focusing on Health IT With Latest Fund, Genzyme Isis Cholesterol Drug Shows Strong in Clinical Trial, & More Boston-Area Life Sciences News	Erin Kutz	08/06/10	Boston
Genzyme, Isis Cholesterol Drug Passes Pair of Clinical Trials; Shares Fall Anyway	Luke Timmerman	08/04/10	Boston
SonoSite’s New Push: Ultrasound for an Up-Close Look at Heart Attack Risk	Luke Timmerman	07/26/10	Seattle
Lessons Learned About the Outlook for New Obesity Drug Approval	Tom Hughes	07/16/10	National
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News	Denise Gellene	03/11/10	San Diego
Isis Nabs $6M Bristol Payment	Luke Timmerman	03/08/10	San Diego
Isis, Genzyme Cholesterol Drug Passes Test, But Investors Get Nervous About Liver Safety	Luke Timmerman	11/17/09	San Diego
Isis CEO Vows that Cholesterol Drug, Partnered With Genzyme, Will be “Remarkable” Advance	Luke Timmerman	10/21/09	San Diego
Oscient Pharma Seeks Bankruptcy, Finds Buyer for No. 2 Product	Ryan McBride	07/14/09	Boston
Genzyme, Isis Cholesterol Drug Reaches Goal in Pivotal Study, Paving the Way to FDA	Luke Timmerman	05/20/09	Boston
Genzyme, Isis Begin New Drug Trials	Ryan McBride	01/12/09	Boston
Genzyme Thinks Small, and Big, With Cholesterol-Lowering Drug Mipomersen	Luke Timmerman	09/29/08	Boston
Genzyme, Isis Start Pivotal Trial for High Cholesterol	Luke Timmerman	08/06/08	Boston
MediQuest Therapeutics Persuades FDA to Do 6-Month Review of Lead Product	Luke Timmerman	06/25/08	Seattle
Genzyme, Isis Finalize Partnership For Cholesterol-Lowering Drug	Luke Timmerman	06/24/08	Boston
Page 1 of 1